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ABSTRACT
The role of Legionella spp. in the aetiology of acute
respiratory infections (ARIs) is largely unknown.
In this case-control study, conducted in a general
practitioner setting during 2000 and 2001, nose
and throat samples from patients presenting with
ARIs (n = 230) and controls (n = 200) were ana-
lysed for the presence of Legionella spp. by real-
time PCR. Legionella DNA was not detected in any
of the cases or controls. Thus, Legionella spp. do
not seem to play a role in patients presenting with
ARIs, nor were they present in patients who
visited their general practitioner for complaints
other than ARIs.
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Legionella spp. are an important cause of commu-
nity-acquired and nosocomial pneumonia. Since
the ﬁrst description of Legionella pneumophila,
more than 40 species of Legionella have been
identiﬁed, approximately half of which have been
isolated from patients [1]. Infection with Legionella
spp. can present as a severe pneumonia, with or
without multisystem disease and high mortality,
but can also present as a self-limiting inﬂuenza-
like illness. Many individuals who seroconvert to
Legionella are entirely asymptomatic [1,2].
Acute respiratory infections (ARIs) are a major
cause of morbidity and mortality worldwide.
Various infectious agents, especially viruses, have
been associated with clinical syndromes ranging
from mild disease, such as the common cold, to
more severe conditions, such as pneumonia.
However, no aetiological agent is found in a large
percentage of cases [3]. Although ARIs are very
common, there is only one report on the preval-
ence of Legionella spp. as a cause of community-
acquired infections in general practice [4]. This
may be because the diagnosis is not considered,
existing diagnostic tests are insensitive, or legio-
nellosis is distributed unevenly across the world.
In The Netherlands, c. 200 cases of severe legio-
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nellosis are reported annually to the health
authorities [5].
The aim of this study was to assess the
frequency of Legionella spp. in nose and throat
samples of patients presenting with ARIs in
general practice. In The Netherlands, more than
100 general practitioners (GPs) participate in
nationwide surveillance of respiratory pathogens
and inﬂuenza-like illnesses, coordinated by the
Netherlands Institute for Health Services Re-
search (NIVEL, Utrecht, The Netherlands) [6].
The GPs register all patients with inﬂuenza-like
illness and other ARIs. ARIs without inﬂuenza-
like illness are deﬁned as respiratory infections
with acute onset (< 5 days) and coryza, sore
throat and ⁄ or cough. Twenty GPs participated
in the present study and were requested to
collect a nose and throat sample from patients
with ARIs without inﬂuenza-like illness (case). A
corresponding control was also sampled within
7 days, deﬁned as an individual who consulted
the GP for a complaint other than ARIs, who
was in the same age category as the case (0–4,
5–14, 15–24, 25–44, 45–64 or > 65 years), was not
a member of the same household as the case,
and had not received antibiotics or antiviral
therapy in the preceding 14 days. A nose and a
throat swab were placed together in 4 mL of
Hanks’ balanced salt solution containing gelatin,
lactalbumin, yeast and antibiotics (GLY med-
ium), and sent to the central laboratory by
regular mail. Swabs for bacterial culture were
also taken.
The primers and probes of the Legionella PCR
assay were based on the 16S rRNA gene as
described previously [7]. In brief, nucleic acid
isolation was performed with a proteinase K lysis
protocol, and primers Leg1 (5¢-TACCTACC-
CTTGACATACAGTG-3¢) and Leg2 (5¢-CTTCC-
TCCGGTTTGTCAC-3¢) were used to obtain a
200-bp amplicon. Real-time detection of the frag-
ment was done with a Legionella genus-speciﬁc
ﬂuorescent probe conjugated to a minor groove
binder (LSPP-VIC: 5¢-GGTTGCGTCGTTACG-3¢).
An L. pneumophila-speciﬁc ﬂuorescent minor
groove binder probewas used on the complement-
ary DNA strand (LPN-FAM: 5¢-GAGTCCCC-
ACCATCACATG-3¢). Inhibition was monitored
in a separate assay by amplifying a phocine herpes
virus, and negative controls were included to
monitor processing and cross-contamination. Sen-
sitivity controls comprised ten-fold dilutions of
L. pneumophila DNA (1000 fg to 10 fg), while
1000 fg of Legionella bozemanii DNA served as a
control for discrimination between L. pneumophila
and other Legionella spp.
Real-time PCR was performed with an ABI
Prism 7900HT Sequence Detection System
(Applied Biosystems, Foster City, CA, USA).
Nose and throat samples from 230 cases and
200 controls were collected between October 2000
and November 2001. The median age of the cases
was 35 years (range 0–87 years), and 104 (45%) of
them were male. The median age of the control
patients was 36 years (range 0–86 years), and 76
(38%) of them were male. Evidence of at least one
infectious agent was found by standard tech-
niques in 146 (63%) of the cases, compared to 44
(22%) of the controls (Table 1). Real-time PCR
failed to detect Legionella DNA in any of the
samples from either the patients with ARI or the
control group. Inhibition of the PCR occurred
with one sample.
ARIs are the most common diseases seen in the
community and a frequent reason to consult a GP.
Knowledge of the causes of respiratory infections
continues to evolve, with recognition of new
pathogens [8], but no aetiological diagnosis is
established in a large percentage of cases [3]. It
might be expected that Legionella spp. could play a
role in ARIs, as they are ubiquitous in the aquatic
environment and artiﬁcial water systems, and can
cause a variety of diseases, ranging from asymp-
tomatic cases to severe life-threatening pneu-
monia [1,9]. Upper respiratory signs and
symptoms, such as a dry cough and sore throat,
have been reported in cases of Legionnaires’
Table 1. Frequency of detection of speciﬁc infectious
agents in 230 cases of acute respiratory tract infection
and 200 control patients
Pathogen Cases n (%) Controls n (%)
Inﬂuenza virus A 25 (10) 2 (1)
Inﬂuenza virus B 7 (3) 0 (0)
Parainﬂuenza virus 1 3 (1) 0 (0)
Parainﬂuenza virus 2 0 (0) 0 (0)
Parainﬂuenza virus 3 2 (1) 0 (0)
Rhinovirus 61 (25) 23 (11)
Adenovirus 2 (1) 0 (0)
Coronavirus 20 (8) 11 (5)
Respiratory syncytial virus 6 (3) 2 (1)
Human metapneumovirus 5 (2) 0 (0)
Enterovirus 7 (3) 3 (1)
Chlamydia pneumoniae 2 (1) 0 (0)
Mycoplasma pneumoniae 3 (1) 1 (0)
b-Haemolytic streptococci 20 (9) 4 (2)
One or more of the above 146 (63) 44 (22)
Negative 84 (37) 156 (78)
Total 230 (100) 200 (100)
Research Note 411
 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 11, 402–421
disease [10], and a previous study [4] found
serological evidence of infection with Legionella
spp. in 11.2% of patients who presented with a
febrile respiratory tract infection. However, obser-
vations based solely on antibody seroconversion
should be viewed with scepticism, as the sensi-
tivity and speciﬁcity of serology for Legionella spp.
other than L. pneumophila have not been validated,
and cross-reactions with other organisms may
occur [1,11,12].
Culture on buffered charcoal yeast extract
(BCYE) plates is the standard method for the
laboratory diagnosis of Legionella infections, but
has its limitations. Isolates are identiﬁed by a
combination of colony and Gram’s stain morphol-
ogy, and reactions with speciﬁc antibodies. How-
ever, because of the fastidious nature of the
organism and problems inherent in specimen
collection, culture of clinical specimens may have
a sensitivity as low as 10% [11]. Moreover, several
non-pneumophila Legionella spp. tend to grow
poorly on BCYE agar [13]. Nucleic acid ampliﬁca-
tion techniques are attractive tools for detection of
Legionella spp. in clinical samples, as they are able
todetect all legionellae andprovide results rapidly.
Several studies have found that PCRmethods have
a higher rate of detection than culture-based
methods [14–16]. In the present study, the assay
sensitivity was 10 fg for all Legionella spp., equiv-
alent to two bacterial cells ⁄ reaction.
Throat swabs have been used successfully to
detect respiratory pathogens such as Mycoplasma
pneumoniae [17], Chlamydia pneumonia [17,18] and
Legionella spp. [16,17] by PCR. In contrast to a
previous report based on serological observations
[4], Legionella spp. were not detected in the nose or
throat of patientswithARIs in general practice, and
no evidence was found for asymptomatic carriage
of Legionella spp. in the upper respiratory tract.
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